Moreover, a roles of galectin-3 in IPF was demonstrated [27,28], and inhibitors of galectin-3 were recently proposed to treat fibrotic disease as well as IPF [29,30]. The gene discussed is LGALS3; the disease is idiopathic pulmonary fibrosis.